| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.08 |